<SEC-DOCUMENT>0001415889-24-024706-index.html : 20241003
<SEC-HEADER>0001415889-24-024706.hdr.sgml : 20241003
<ACCEPTANCE-DATETIME>20241003203014
ACCESSION NUMBER:		0001415889-24-024706
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20241001
FILED AS OF DATE:		20241003
DATE AS OF CHANGE:		20241003

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Auffarth Gerd
		CENTRAL INDEX KEY:			0001649867
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37759
		FILM NUMBER:		241353306

	MAIL ADDRESS:	
		STREET 1:		C/O PRESBIA PLC
		STREET 2:		120/121 BAGGOT STREET LOWER
		CITY:			DUBLIN 2
		STATE:			L2
		ZIP:			00000

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Outlook Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001649989
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				383982704
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	BUSINESS ADDRESS:	
		STREET 1:		111 S. WOOD AVENUE
		STREET 2:		UNIT #100
		CITY:			ISELIN
		STATE:			NJ
		ZIP:			08830
		BUSINESS PHONE:		6096193990

	MAIL ADDRESS:	
		STREET 1:		111 S. WOOD AVENUE
		STREET 2:		UNIT #100
		CITY:			ISELIN
		STATE:			NJ
		ZIP:			08830

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Oncobiologics, Inc.
		DATE OF NAME CHANGE:	20150804
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4-10032024_081011.xml
<TEXT>
Document 1 - file: form4-10032024_081011.html

Document 1 - RAW XML: form4-10032024_081011.xml

</DOCUMENT>
</SEC-DOCUMENT>